Skip to content

To Investigate the Prevalence of Children Asthma in China

To Investigate the Prevalence of Children Asthma in China and Compare With That of the Last 20 Years

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01319292
Enrollment
20000
Registered
2011-03-21
Start date
2011-04-30
Completion date
2014-04-30
Last updated
2014-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Brief summary

Asthma is the most common chronic respiratory disease in children and has much effect on their life and study, which leads to huge economic burden and pressure to the whole families. Some children will develop into adult patients so that asthma can be the life-long vigorous trouble. In recent years, the prevalence rate of children asthma is increasingly going up worldwide. The prevalence rate in last 12 months reported in USA, United Kingdom, Australia, New Zealand was between 12% to 30%. Center for Asthma Prevention and Education of Capital Institute of Pediatrics investigated the national asthma prevalence in 900 thousands children in 27 provinces and cities, which average rate was 0.11% to 2.03% in 1990. In 2000, we investigated it again in 31 provinces(43 cities) and the average national children asthma prevalence rate was 1.97%(0.25% to 4.63%) which was much higher than that in 1990.

Detailed description

1. Objectives 1. To investigate the national children(0-14 years old)asthma prevalence; 2. To compare the prevalence rate between that in 1990 and 2000; 3. To analyse the asthma manifestations including the ages, seasons, causes, trigger and hereditary factors and their impact on the asthma patients, families and society; 4. To identify the risk factors by questionnaires in case-control research. 2. Study Design / Clinical Plan 1. The screening stage: to distinguish suspected asthma from the children age from 0 to 14 years old. 2. To obtain identified asthma from the suspected asthma. 3. To evaluate the prevalence and severe degree of 0 to 14-year-old children asthma and gain the main risk factors by case-control research.

Interventions

None listed

Sponsors

Merck Sharp & Dohme LLC
CollaboratorINDUSTRY
Capital Institute of Pediatrics, China
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 14 Years
Healthy volunteers
No

Inclusion criteria

* children age from 0 to 14 years

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frame
prevalence of asthmaApr 2013

Secondary

MeasureTime frame
prevalence of allergic rhinitisApr 2013

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026